LncRNA cancer susceptibility candidate 2 (CASC2) sequesters and suppresses onco-miR-21 responsible for the malignant progression of human gliomas and on the other hand, miR-21 targets CASC2 [147]. The gene discussed is CASC2; the disease is glioma.